The rising prevalence in GLP-1 agonists for diabetes has generated a question about formats: skin-applied devices versus pills . Traditionally , GLP-1 treatments were exclusively available in oral form, but https://sidneyyssy974317.fitnell.com/82005106/glp-1-transdermal-delivery-systems-vs-pills-which-right-for-individuals